Pp. Vanveldhoven et al., THE DEFICIENT DEGRADATION OF SYNTHETIC 2-METHYL-BRANCHED AND 3-METHYL-BRANCHED FATTY-ACIDS IN FIBROBLASTS FROM PATIENTS WITH PEROXISOMAL DISORDERS, Journal of inherited metabolic disease, 16(2), 1993, pp. 381-391
The oxidation of pristanic and phytanic acids by human skin fibroblast
s was compared to that of their synthetic analogues, 2-methylpalmitic
and 3-methylmargaric acids. The synthetic compounds and natural substr
ates were degraded at comparable rates in control and X-linked adrenol
eukodystrophy fibroblasts. The alpha-decarboxylation of 3-methylmargar
ic acid, similarly to that of phytanic acid, was affected in Refsum di
sease and Zellweger syndrome, but not in X-linked adrenoleukodystrophy
. The beta-oxidation of 2-methylpalmitic acid, similarly to that of pr
istanic acid, was deficient in fibroblasts derived from patients suffe
ring from Zellweger syndrome, confirming the importance of peroxisomes
in the breakdown of 2-methyl-branched fatty acids. No deficiency was
observed in fibroblasts from X-linked adrenoleukodystrophy patients. T
he 1-C-14-labelled 2- and 3-methyl-branched fatty acids, which are eas
ier to synthesize that the natural analogues, are therefore valuable t
ools for the diagnosis of human peroxisomal disorders.